Second Cellectis CAR-T Therapy On Clinical Hold, Dosing Could Be Issue

long exposure on road at night
A Phase I trial for UCARTCS1A was halted after a patient died from cardiac arrest • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D